Lanzhou Foci Pharmaceutical Co.,Ltd.’s Net Profit Rose 11% in First Three Quarters of 2023

Lanzhou Foci Pharmaceutical Co.,Ltd. (兰州佛慈制药股份有限公司) (002644.SZ) reported a net profit of 59 million yuan in the first three quarters of 2023, up 11% year-on-year.

Meanwhile, the company posted 860.5 million yuan in revenue, up 23.2% year-on-year.

At the end of the reporting period, it had 2.6 billion yuan in total assets and 794.1 million yuan in total liabilities, with a liability-to-asset ratio of 31%.